Skip to content

Insider · CIK 0001239546

Andrew S Boyer

officer

Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing Mar 7, 2025, latest Mar 7, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AMRX: Amneal Pharmaceuticals, Inc.

AMRXOct 9, 2026 · close 19.91

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
65Notable
AMRXsell 6
Amneal Pharmaceuticals, Inc.
$1.1M
125,000 shares
-30%+17% from low-3% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026AMRX
Amneal Pharmaceuticals, Inc.
GGift
Class A Common Stock
-80,000$0.00$0193,64639 d ago
Mar 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
SOpen-market sale
Class A Common Stock
-125,000$8.89$1.1M290,106Mar 7, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+39,251--315,555Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
FTax withholding
Class A Common Stock
-20,077$8.76$176k295,478Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+49,694--345,172Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
FTax withholding
Class A Common Stock
-25,419$8.76$223k319,753Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+157,005--476,758Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
FTax withholding
Class A Common Stock
-80,309$8.76$704k396,449Mar 5, 2025
Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+38,194--434,643Mar 5, 2025
Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
FTax withholding
Class A Common Stock
-19,537$8.84$173k415,106Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-39,251$0.00$039,252Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-49,694$0.00$099,389Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Performance-Based Restricted Stock Unitsderivative
-157,005$0.00$00Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
AGrant or award
Performance-Based Restricted Stock Unitsderivative
+194,064$0.00$0194,064Mar 5, 2025
Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
AGrant or award
Restricted Stock Unitsderivative
+97,032$0.00$097,033Mar 5, 2025
Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-38,194$0.00$0114,582Mar 5, 2025
Mar 1, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+31,371--288,041Mar 4, 2025
Mar 1, 2025AMRX
Amneal Pharmaceuticals, Inc.
FTax withholding
Class A Common Stock
-11,737$8.67$102k276,304Mar 4, 2025
Mar 1, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-31,371$0.00$00Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew S Boyer: insider trades and track record | InsiderTell